KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Other financing activities: 2012-2025

Historic Other financing activities for National Health Investors (NHI) over the last 6 years, with Jun 2025 value amounting to $138,000.

  • National Health Investors' Other financing activities rose 97.14% to $138,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $3.6 million, marking a year-over-year increase of 18.34%. This contributed to the annual value of $3.5 million for FY2024, which is 17.26% up from last year.
  • Latest data reveals that National Health Investors reported Other financing activities of $138,000 as of Q2 2025, which was up 193.62% from $47,000 recorded in Q1 2025.
  • In the past 5 years, National Health Investors' Other financing activities registered a high of $20.6 million during Q2 2022, and its lowest value of -$8.8 million during Q1 2022.
  • For the 3-year period, National Health Investors' Other financing activities averaged around $830,500, with its median value being $425,000 (2024).
  • Per our database at Business Quant, National Health Investors' Other financing activities soared by 34,200.00% in 2021 and then slumped by 298.21% in 2022.
  • National Health Investors' Other financing activities (Quarterly) stood at $559,000 in 2021, then spiked by 3,580.86% to $20.6 million in 2022, then slumped by 95.52% to $51,000 in 2023, then soared by 5,201.96% to $2.7 million in 2024, then skyrocketed by 97.14% to $138,000 in 2025.
  • Its Other financing activities stands at $138,000 for Q2 2025, versus $47,000 for Q1 2025 and $2.7 million for Q4 2024.